These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 19364290

  • 1. Activation adverse events induced by the selective serotonin reuptake inhibitor fluvoxamine in children and adolescents.
    Reinblatt SP, DosReis S, Walkup JT, Riddle MA.
    J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):119-26. PubMed ID: 19364290
    [Abstract] [Full Text] [Related]

  • 2. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group.
    N Engl J Med; 2001 Apr 26; 344(17):1279-85. PubMed ID: 11323729
    [Abstract] [Full Text] [Related]

  • 3. Pilot study: fluvoxamine treatment for depression and anxiety disorders in children and adolescents with cancer.
    Gothelf D, Rubinstein M, Shemesh E, Miller O, Farbstein I, Klein A, Weizman A, Apter A, Yaniv I.
    J Am Acad Child Adolesc Psychiatry; 2005 Dec 26; 44(12):1258-62. PubMed ID: 16292117
    [Abstract] [Full Text] [Related]

  • 4. Selective serotonin reuptake inhibitor-induced apathy: a pediatric case series.
    Reinblatt SP, Riddle MA.
    J Child Adolesc Psychopharmacol; 2006 Dec 26; 16(1-2):227-33. PubMed ID: 16553543
    [Abstract] [Full Text] [Related]

  • 5. Child/Adolescent anxiety multimodal study: evaluating safety.
    Rynn MA, Walkup JT, Compton SN, Sakolsky DJ, Sherrill JT, Shen S, Kendall PC, McCracken J, Albano AM, Piacentini J, Riddle MA, Keeton C, Waslick B, Chrisman A, Iyengar S, March JS, Birmaher B.
    J Am Acad Child Adolesc Psychiatry; 2015 Mar 26; 54(3):180-90. PubMed ID: 25721183
    [Abstract] [Full Text] [Related]

  • 6. Fluvoxamine for the treatment of anxiety disorders in children and adolescents.
    Isaacs E.
    N Engl J Med; 2001 Aug 09; 345(6):466-7. PubMed ID: 11496864
    [No Abstract] [Full Text] [Related]

  • 7. Fluvoxamine treatment of mixed anxiety and depression: evidence for serotonergically mediated anxiolysis.
    Rausch JL, Hobby HM, Shendarkar N, Johnson ME, Li J.
    J Clin Psychopharmacol; 2001 Apr 09; 21(2):139-42. PubMed ID: 11270909
    [Abstract] [Full Text] [Related]

  • 8. Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders.
    Abikoff H, McGough J, Vitiello B, McCracken J, Davies M, Walkup J, Riddle M, Oatis M, Greenhill L, Skrobala A, March J, Gammon P, Robinson J, Lazell R, McMahon DJ, Ritz L, RUPP ADHD/Anxiety Study Group.
    J Am Acad Child Adolesc Psychiatry; 2005 May 09; 44(5):418-27. PubMed ID: 15843763
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.
    Stein MB, Fyer AJ, Davidson JR, Pollack MH, Wiita B.
    Am J Psychiatry; 1999 May 09; 156(5):756-60. PubMed ID: 10327910
    [Abstract] [Full Text] [Related]

  • 14. Fluvoxamine or placebo in the treatment of panic disorder and relationship to blood concentrations of fluvoxamine.
    Sandmann J, Lörch B, Bandelow B, Härtter S, Winter P, Hiemke C, Benkert O.
    Pharmacopsychiatry; 1998 Jul 09; 31(4):117-21. PubMed ID: 9754844
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.
    Sonawalla SB, Spillmann MK, Kolsky AR, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M.
    J Clin Psychiatry; 1999 Sep 09; 60(9):580-3. PubMed ID: 10520975
    [Abstract] [Full Text] [Related]

  • 16. A double-blind placebo-controlled study of controlled release fluvoxamine for the treatment of generalized social anxiety disorder.
    Westenberg HG, Stein DJ, Yang H, Li D, Barbato LM.
    J Clin Psychopharmacol; 2004 Feb 09; 24(1):49-55. PubMed ID: 14709947
    [Abstract] [Full Text] [Related]

  • 17. Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial.
    Riddle MA, Reeve EA, Yaryura-Tobias JA, Yang HM, Claghorn JL, Gaffney G, Greist JH, Holland D, McConville BJ, Pigott T, Walkup JT.
    J Am Acad Child Adolesc Psychiatry; 2001 Feb 09; 40(2):222-9. PubMed ID: 11211371
    [Abstract] [Full Text] [Related]

  • 18. SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder.
    Rinne T, van den Brink W, Wouters L, van Dyck R.
    Am J Psychiatry; 2002 Dec 09; 159(12):2048-54. PubMed ID: 12450955
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.